|
⚲
|
| Keyboard |
| Torley Helen
✚
|
|
|---|---|
| CIK # | 0001528185 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001528185] | |
| 4 | [0001528185] | |
| 5 | [0001528185] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Torley Helen | |
| Halozyme Therapeutics Inc | |
| Quest Diagnostics Inc | |
| Relypsa Inc | |
| Onyx Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-04 | Sell | 7,329 | $69.94 | 512,590 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-04 | Sell | 2,671 | $70.95 | 189,507 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-03-04 | Option exercise | 10,000 | $12.07 | 120,700 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-04 | Option exercise | 10,000 | $12.07 | 120,700 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-03 | Sell | 13,481 | $68.85 | 928,167 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-03 | Sell | 6,519 | $69.33 | 451,962 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-03-03 | Option exercise | 20,000 | $12.07 | 241,400 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-03 | Option exercise | 20,000 | $12.07 | 241,400 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-02 | Sell | 4,100 | $69.20 | 283,720 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-02 | Option exercise | 20,000 | $12.07 | 241,400 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-02 | Sell | 15,322 | $69.80 | 1,069,476 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-02 | Sell | 578 | $70.46 | 40,726 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-03-02 | Option exercise | 20,000 | $12.07 | 241,400 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-23 | Option exercise | 22,436 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-02-23 | Option exercise | 22,436 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-23 | Tax withheld | 12,104 | $70.64 | 855,027 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-20 | Option exercise | 16,757 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-20 | Tax withheld | 9,040 | $70.98 | 641,659 |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-02-20 | Option exercise | 16,757 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-16 | Tax withheld | 11,334 | $79.44 | 900,373 |
| showing 20 of 200 most recent transactions | |||||